← Leaderboards
Vikram Srivastava
Neovaxsyn, Inc.
$448,656
Attributed
$597,312
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$597,312 · 2
By mechanism
N43$300,000 · 1
R43$297,312 · 1
Top collaborators
- Michael W Cho1 shared
Others in their field
Other Rising Stars on “Transgenic Mice”
- John Alam · Eip Pharma, Inc.$10,411,018
- Amanda L. Woerman · University Of Massachusetts Amherst$4,303,175
- Baodong Sun · Duke University$3,238,660
- Rachel M Olson · University Of Missouri-Columbia$2,769,103
- Paul Tang · University Of Michigan At Ann Arbor$2,648,134
- Vishnu Hosur · Jackson Laboratory$2,568,438
Research focus
Transgenic MiceAntibody ResponsePeptidesVaccine CandidateGenesAntibodiesHiv-1Neutralizing AntibodyVaccine StrategyAntigensInnovationCellsAnimal ModelCellular MembraneB-LymphocytesAnti-Retroviral AgentsAmino AcidsAids Vaccine DevelopmentEvaluationEpitopesC-TerminalFaceFeasibility StudiesAntigen-Antibody Complex